American Cannabis Company Inc. Obtains Services Contract with a Missouri Based Business
American Cannabis Company Inc. (AMMJ) (“ACC” or the “Company”), a full-service cannabis industry consultant and provider of proprietary and preferred products, today announced that it has secured a consulting contract in the state of Missouri. The Company anticipates generating advisory and consulting revenues pursuant to the contract beginning in the second quarter of this year.
The contract focuses on ACC’s expertise with pre-business planning and application work for the Missouri entrepreneurs and their newly established business. ACC expects to leverage this contract to secure additional revenues through long-term consulting contracts and potential sales of ancillary products and services to aid cultivating, refining and dispensing operations.
“We are very excited for our client in Missouri to secure one of the licenses to operate a medical cannabis business and bring the best possible medicine to Missouri patients,” began ACC CEO Corey Hollister. “With the limited number of licenses, Missouri will be a large market and our client is intent on receiving permission to operate a medical cannabis cultivation and dispensing license. This vertically integrated business will allow the entity to service their patients accordingly. Missouri will continue to allow ACC to build our track record on winning marquee licenses for our clients and demonstrate our expertise, nationwide capabilities and brand recognition.”
About American Cannabis Company:
American Cannabis Company (“ACC”) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and The Trade Winds, a group purchasing organization, we support our clients from concept to creation to commercialization.
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
Contact:
Trent Woloveck
Chief Operating Officer
trent@americancannabisconsulting.com
303-974-4770
SOURCE: American Cannabis Company Inc.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com